# Remifentanil vs Esmolol During Intubation for Cerebral Aneurysm Coil Embolization

> **NCT07660861** · NA · NOT_YET_RECRUITING · sponsor: **Fatih Sultan Mehmet Training and Research Hospital** · enrollment: 84 (estimated)

## Conditions studied

- Cerebral Aneurysm Unruptured
- Intracranial Pressure

## Interventions

- **DRUG:** Remifentanil
- **DRUG:** Esmolol

## Key facts

- **NCT ID:** NCT07660861
- **Lead sponsor:** Fatih Sultan Mehmet Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-22
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2026-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07660861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07660861, "Remifentanil vs Esmolol During Intubation for Cerebral Aneurysm Coil Embolization". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07660861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*